A condition, known commonly as "black urine disease" or Alkaptonuria is a rare genetic disorder involving protein metabolism, and it has its root in the mutation of the homogentisate 1,2-dioxygenase gene, which in turn causes homogentisic acid accumulation in the body. The appearance of dark urine after exposure to air is due to this kind of accumulation; however, a variety of symptoms can be expected, such as joint stiffness, changes in pigmentation, and other long-term health complications. Although the prevalence has been estimated to be between 1 in 250,000 and 1 in 1 million people in the United States, its effects are indeed high on those affected.

Alkaptonuria is an autosomal recessive disease, meaning that the child must inherit a defective copy of the HGD gene from both parents. If both parents are carriers, their offspring have a 25% chance of inheriting two faulty genes and developing alkaptonuria. The condition is genetic but is often not diagnosed for years because it progresses slowly and its early symptoms appear to be harmless.

Symptoms of Alkaptonuria

The most characteristic and common initial symptom of alkaptonuria is dark urine. The reason for this is due to the fact that excess HGA is excreted in the urine and upon oxidation in the presence of air, it gives the urine a brown or black color. Though it is often considered cosmetic, the long-term accumulation of HGA within the connective tissues produces more complicated health problems.

Progressive joint pain and stiffness: The accumulation of HGA in cartilage leads to early-onset osteoarthritis, making movement increasingly difficult over time.

Skin and eye pigmentation changes: Affected individuals may develop bluish or grayish discoloration of the sclera (white part of the eye) and the skin, particularly in areas exposed to friction.

Cardiovascular and respiratory problems: With age, HGA accumulation can lead to valve calcifications in the heart and stiffening of connective tissues in the respiratory tract, which can cause problems in middle and old age.

Decreased mobility and spinal problems: The spine may become stiff and painful due to chronic cartilage degeneration.

These symptoms usually begin to manifest during adulthood, leading to severe complications in a person's 40s or 50s and significantly affecting the quality of their life.

How is Alkaptonuria Diagnosed?

Because of its rarity, alkaptonuria is often mistaken or overlooked early in life. However, there are several ways to confirm the condition:

Urine Testing: The gold standard in the diagnosis is the testing of urine samples for high levels of homogentisic acid via gas chromatography. In case of oxidation, which changes the color of urine to black, it is indicative of alkaptonuria.

Genetic Testing: Confirmatory genetic testing reveals mutations of the HGD gene to diagnose the condition conclusively.

Blood Tests: High levels of HGA in the blood can be used as further evidence.

Imaging Studies: X-rays and MRIs will expose cartilage and joint damage characteristic of alkaptonuria.

Management of Alkaptonuria: Is There A Cure?

At present, there is no cure for alkaptonuria; however, various treatment approaches can reduce its symptoms and slow the disease's progress:

Nitisinone Therapy: Nitisinone is a drug that inhibits the production of HGA. It has been shown to reduce HGA levels and slow tissue damage. However, it needs to be taken under close medical supervision because of potential side effects.

Low-Protein Diet: Since HGA is a byproduct of protein metabolism, reducing protein intake—especially foods rich in tyrosine and phenylalanine—may help decrease HGA production.

Pain Management: OTC pain relievers and anti-inflammatory medications can be used to relieve joint pain and stiffness.

Physical Therapy: Exercise regularly, as it may improve mobility and strengthen muscles, thus reducing strain on affected joints.

Surgical Interventions: Most people with alkaptonuria develop severe osteoarthritis necessitating joint replacement in their old age. Also, some may require heart valve replacement surgery if cardiovascular complications develop.

Life with Alkaptonuria

Although alkaptonuria is not fatal, it severely affects the quality of life. The progressive deterioration of the joints and associated symptoms can make everyday activities difficult, requiring lifestyle changes and medical interventions. The disease may cause premature aging of the joints, requiring walking aids and mobility assistance earlier than expected.

Ongoing research will continue to work on improving the treatment options by focusing on gene therapy and alternative enzyme replacement therapies. However, because of its rarity, the clinical trials and research remain sparse.

As genetic research advances, more hope for better management and possible curative approaches for alkaptonuria exists. Scientists are searching extensively for enzyme replacement therapies and innovative drugs that can target the root cause of the disorder. Being aware and being diagnosed early helps individuals better their condition and ultimately have better long-term health outcomes.

Alkaptonuria is a striking example of how one gene mutation can have widespread effects on the body. Though still a rare and often misunderstood condition, growing awareness and advances in treatment are paving the way for better care. If you or a loved one suspect symptoms of alkaptonuria, it is essential to seek early diagnosis and medical guidance to manage the disease effectively and preserve quality of life.

Parkinson’s Disease is traditionally characterized by motor symptoms such as tremor and dyskinesia, although non-motor symptoms, in particular gastrointestinal (GI) symptoms such as constipation and incomplete emptying, are often the first markers of the disease and may precede the motor symptoms by years.

GI dysfunction is reported in approximately 70-80 per cent of Parkinson’s patients, mediated in large part through the gut-brain axis (GBA).

Speaking to HealthandMe, Dr Paresh Doshi, Director of Neurosurgery and Stereotactic and Functional Neurosurgery at Jaslok Hospital and Research Center, GBA, is an established two-way network that links the GI tract and the central nervous system (CNS). The connection is multifaceted, involving the vagus nerve, the enteric nervous system (ENS), the immune system, and a vast number of microbial metabolites and neuroendocrine signals.

“Constipation is seen in 66 per cent of Parkinson’s patients, attributed to disordered central and peripheral parasympathetic disruption, and can lead to alteration of the gut microbiome, which in turn worsens constipation, starting a feedback loop,” the doctor explained.

What Parkinson’s Patients Must Eat

Dr Sudhir Kumar, Neurologist at Apollo Hospitals Hyderabad, told HealthandMe that changes in the gut microbiome may influence inflammation, α-synuclein aggregation, and symptom progression.

Practical dietary principles for Parkinson’s patients include:

• Prefer fiber-rich, plant-based foods (vegetables, fruits, whole grains), which support gut microbiota
• Include fermented foods (curd, buttermilk), which may improve microbial diversity
• Reduce ultra-processed and pro-inflammatory foods
• Ensure adequate hydration (helps reduce the risk of constipation, a common non-motor symptom)
• Protein timing matters: Levodopa competes with amino acids for absorption.

These gut-targeted interventions are promising adjuncts to conventional Parkinson's therapy, and improving patient quality of life.

Parkinson’s Treatment With Dance, Art

Beyond gut-brain axis, research has proven that unconventional therapy, like dance and art, can improve Parkinson’s treatment.

A 2024 study published in the Scientific Reports found that tango, particularly Argentine tango, improved Parkinson's symptoms like thinking problems or balance issues. It also led to a significant improvement in recognizing emotions on people's faces.

Dr Kumar said dance therapy improves balance, gait, and coordination; provides rhythmic cueing, which enhances motor performance, and improves mood and motivation (dopamine-related pathways).

Similarly, art therapy has been shown to improve overall visual-cognitive skills and visual exploration strategies as well as general motor function in patients with Parkinson’s. The changes in brain connectivity highlight a functional reorganization of visual networks, as revealed by a study published in Parkinsonism & Related Disorders.

Dr Kumar said art and creative therapies are also helpful in enhancing cognitive engagement. It may help with executive function and emotional well-being and provide a non-verbal outlet for expression. However, these therapies work best as adjuncts, not replacements, to standard treatment, the expert noted.

World Parkinson’s Day 2026

World Parkinson's Day is observed annually on April 11 to raise global awareness of Parkinson’s disease, the world's fastest-growing neurodegenerative disorder.

It highlights the need for early diagnosis, research, and support for the nearly 10 million people living with the condition. The day marks the birthday of Dr. James Parkinson, who first described the disease in 1817.

The theme of World Parkinson's Day 2026 is "Bridge the Care Gap." It reflects a critical challenge that persists despite advances in medical research: many people living with Parkinson's still lack consistent access to specialist care, affordable treatment, and integrated support systems.

Parkinson's disease affected 11.9 million people in 2021 and will affect 25.2 million people globally by 2050, representing an alarming 112 per cent rise.

For most working professionals, Parkinson’s disease still feels like something that happens much later in life. It’s not something people in their 30s or even early 40s actively think about. But this scenario is changed with early onset Parkinson’s disease (EOPD). This can affect people between the ages of 21 and 50.

The problem is not just the condition itself, but how it subtly integrates into everyday life. Despite this shift, early symptoms in working professionals often go unnoticed or are misattributed to stress, fatigue, or demanding work schedules.

What Is Early-Onset Parkinson’s Disease?

Parkinson’s disease is a neurological condition that affects movement and coordination due to a reduction in dopamine-producing cells in the brain. When it occurs between the ages of 21 and 50, it is referred to as early-onset Parkinson’s disease (EOPD). In younger individuals, the condition often develops slowly and remains mild in the beginning, which makes it harder to recognize. The exact cause may involve a mix of genetic factors and environmental triggers.

Symptoms can include both movement and non-movement changes. Movement-related symptoms may involve muscle stiffness, slowed movements, mild balance issues, tremors at rest, while non-movement symptoms such as constipation, unexplained pain, sexual dysfunction, and sleep disturbances like insomnia may appear early.

In day-to-day life, these changes often show up subtly as slight hand shaking at rest, taking longer to complete routine tasks, stiffness in the neck or shoulders, a softer or less expressive voice, and disturbed sleep patterns, signs that are easy to overlook or dismiss.

What are the symptoms that working professionals may miss?

1. Symptoms Overlap With Lifestyle Issues: In fast-paced work environments, fatigue, body aches, and sleep disturbances are common. Early Parkinson’s symptoms, such as stiffness, low energy, or poor sleep, are often dismissed as burnout or long working hours.

2. Lack of Awareness in Younger Age Groups: Both patients and even healthcare providers may not immediately suspect Parkinson’s in someone in their 30s or 40s. This leads to delays in seeking medical advice and diagnosis.

3. Absence of Classic Tremors Initially: Tremors are widely recognized as a hallmark of Parkinson’s, but they may not appear in the early stages. Instead, symptoms like reduced arm swing while walking or slight slowness in movements may be present but overlooked.

4. Attribution to Mental Health or Stress: Subtle changes such as anxiety, low mood, or difficulty concentrating can be early indicators. However, these are often attributed to workplace stress rather than a neurological cause.

5. Gradual Onset of Symptoms: Parkinson’s develops slowly. Changes in handwriting, posture, or speech may happen over time, making them difficult to notice unless specifically looked for.

How Can Parkinson’s Be Diagnosed and Managed?

Because early signs are often overlooked, the condition is often recognized only when it begins to affect daily life. Diagnosis typically involves a detailed assessment along with blood tests and imaging, such as MRI, and in some cases, specialized scans like a dopamine transporter (DAT) scan may also be advised to support the diagnosis.

Management focuses on improving quality of life through physical therapy to support movement and balance, occupational therapy to make daily activities easier, and speech therapy to address communication changes. In more severe cases, deep brain stimulation (DBS) surgery may be considered to help manage symptoms more effectively.

Parkinson’s at a younger age is often easy to overlook, especially when early signs blend into everyday stress and fatigue. Paying closer attention to overall well-being can help. Staying physically active, following a balanced diet, maintaining good sleep habits, and managing stress levels all play an important role in supporting brain health. Being mindful of small but persistent changes and not brushing them off as routine can go a long way in ensuring timely attention and better long-term.

World Parkinson’s Day is observed every year on April 11 to raise awareness about the progressive, neurodegenerative movement disorder caused by the loss of dopamine-producing brain cells.

People suffering from Parkinson’s face problems in motor movement, tremors, stiffness, and impaired balance. As symptoms progress, people may have difficulty walking, talking, or completing other simple tasks.

The condition primarily affects people over 60, but is now increasingly being seen in young adults. Apart from motor loss, the disease also causes cognitive decline, depression, anxiety, and swallowing problems.

World Parkinson's Day 2026: Origin

Parkinson's Day is observed on the day that marks the birthday of James Parkinson (born in 1755). The London-based doctor was the first to describe Parkinson as a medical condition in 1817, in his famous ‘Essay on the Shaking Palsy’. In 1997, the day was officially established by the European Parkinson’s Disease Association.

World Parkinson's Day 2026: Theme

The theme of World Parkinson's Day 2026 is "Bridge the Care Gap." It reflects a critical challenge that persists despite advances in medical research: many people living with Parkinson's still lack consistent access to specialist care, affordable treatment, and integrated support systems.

The day also aims to raise awareness about neurodegenerative diseases by educating the public about Parkinson's symptoms, causes, and available care.

Global Burden of Parkinson’s

Parkinson's disease affected 11.9 million people in 2021 and will affect 25.2 million people globally by 2050, representing an alarming 112 per cent rise.

According to a 2025 study released by The BMJ, this rise is mainly due to population aging and hence ranks as one of the most rapidly growing neurological disorders based on prevalence and disability. This alarming increase necessitates immediate global health interventions, research innovation, and policy reform to counteract its effects on people and health systems globally.

In addition, lifestyle differences, genetic susceptibility, and environmental exposures can also lead to regional variation in prevalence.

What Happens To Your Brain In Parkinson's Disease?

Parkinson's Disease affects various brain regions, but the primary symptoms arise from the degeneration of neurons in the substantia nigra, a region near the brain's base. This area is crucial for producing dopamine, a chemical messenger essential for smooth and purposeful movement. Research indicates that by the time Parkinson's symptoms become evident, patients have typically lost 60 to 80% or more of these dopamine-producing neurons.

Additionally, individuals with Parkinson’s disease experience a reduction in nerve endings that produce norepinephrine, a neurotransmitter responsible for regulating many involuntary bodily functions, such as heart rate and blood pressure. This loss may account for some non-movement-related symptoms of Parkinson’s, such as fatigue and fluctuations in blood pressure.

How to Prevent Parkinson's

Though there is no cure for Parkinson's disease yet, studies indicate that some lifestyle elements have the potential to shape its incidence and progression.

• Physical Activity – Engaging in regular exercise has been linked to a reduced risk of Parkinson’s, potentially due to its neuroprotective effects.
• Diet and Nutrition – A balanced diet rich in antioxidants, omega-3 fatty acids, and plant-based nutrients may support brain health.
• Environmental Factors – Exposure to pesticides, heavy metals, and air pollution has been associated with an increased risk, suggesting a need for improved public health measures.